Key Stats | |
---|---|
Open | $45.36 |
Prev. Close | $44.61 |
EPS | - |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $245.36M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 45.12 | 45.47 |
52 Week Range | 34.67 | 45.62 |
Ratios | |
---|---|
P/B Ratio | - |
Revenue | - |
Operating M. % | - |
Earnings | - |
Earnings Growth % | - |
EBITDA Margin % | - |
ROE % | - |
EPS | - |
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Unloved Gilead Due For Reversal On Flight-To-Safety Money Flows
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
5 Beaten-Down Top-Ranked ETFs to Buy for a Turnaround
A Look at Pharma ETFs Post Q1 Earnings
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?